Preoperative cardiovascular risk factor control in elective coronary artery bypass graft patients: A failure of present management

Canadian Journal of Cardiology

Volumn 18, Issue 4, 2002, Pages 397-402

  Baskett, Roger J F ^a   Buth, Karen J ^a   Collicott, Cherie ^a   Ross, David B ^a   Hirsch, Gregory M ^a  

^a Maritime Heart Centre   (Canada)

Author keywords

Bypass; Coronary disease; Grafting; Health outcomes; Revascularization; Risk factors

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE CONTROL; DISEASE COURSE; ELECTIVE SURGERY; FEMALE; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MOTIVATION; OBESITY; OUTCOMES RESEARCH; PATIENT EDUCATION; PREOPERATIVE TREATMENT; PREVALENCE; SMOKING; TREATMENT FAILURE;

CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; MALE; MIDDLE AGED; NOVA SCOTIA; OBESITY; OUTCOME ASSESSMENT (HEALTH CARE); PREOPERATIVE CARE; RISK ASSESSMENT; RISK FACTORS; SMOKING;

EID: 0036305438     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Five-year clinical and functional outcome comparing bypass surgery and angioplasty in patients with multivessel coronary disease. A multicenter, randomized trial. Writing group for the Bypass Angioplasty Revascularization Investigation (BARI) Investigators
2. Validation and interdependence with patient-variables of the influence of procedural variables on early and late survival after CABG
3. Two internal thoracic artery grafts are better than one
4. Risk factors of recurrent angina pectoris and of non-fatal myocardial infarction after coronary artery bypass surgery
5. Is return of angina after coronary artery bypass grafting immutable, can it be delayed, and is it important?
6. Coronary bypass graft fate and patient outcome: Angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years
7. Angiographic correlates of graft patency and relationship to clinical outcomes
8. Frequency of repeat coronary bypass or coronary angioplasty after coronary artery bypass surgery using saphenous venous grafts
9. Risk analysis of primary versus reoperative coronary artery bypass grafting
10. Reoperative coronary surgery. Comparative analysis of 6591 patients undergoing primary and 508 patients undergoing reoperative coronary artery bypass
11. Coronary bypass surgery with internal-thoracic-artery grafts - Effects on survival over a 15-year period
12. Effect of smoking status on the long-term outcome after percutaneous coronary revascularization
13. Effects of smoking on survival and morbidity in patients randomized to medical or surgical therapy in the coronary artery surgery study (CASS): 10-year follow-up
14. Late thrombosis of saphenous vein coronary bypass grafts related to risk factors
15. Multivariable risk factor analysis of clinical outcome fifteen years after venous coronary artery bypass graft surgery
16. Smoking and cardiac events after venous coronary bypass surgery: A 15-year follow-up study
17. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts
18. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
19. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Standford coronary risk intervention project (SCRIP)
20. Can lifestyle changes reverse coronary heart disease?
21. Cardiac rehabilitation after myocardial infarction: Combined experience of randomized clinical trials
22. Clinical practice guidelines for the management of diabetes in Canada
23. Recommendations for the management and treatment of dyslipidemia
24. Canadian recommendations for the management of hypertension. Task force for the development of the 1999 Canadian recommendations for the management of hypertension
25. Recommendations on obesity and weight loss
26. Sophisticated primary and secondary atherosclerosis prevention is cost effective
27. A British cardiac society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on secondary prevention through intervention to reduce events) principle results
28. Ten year audit of secondary prevention in coronary bypass patients